Is DMT Really in the Human Brain? What the Research Shows
Yes, DMT has been detected in the human body. It is present in blood, urine, and — critically — cerebrospinal fluid, which strongly suggests central nervous system production rather than just dietary intake. The enzyme INMT (indolethylamine N-methyltransferase), which catalyzes the final step in DMT synthesis, is expressed in human brain tissue. This is Tier 1.
What role endogenous DMT plays — whether it contributes to ordinary consciousness, dreams, near-death states, or mystical experiences — is a different question. The evidence is suggestive but not established. Here is the full picture, tiered honestly, with implications for the Technospermia theory.
The Detection Evidence
The foundational detection studies were conducted by Steven Barker and colleagues. Using highly sensitive analytical methods (gas chromatography–mass spectrometry and related techniques), they detected DMT in human cerebrospinal fluid — the fluid surrounding the brain and spinal cord — as well as in blood and urine.
The cerebrospinal fluid detection is the most significant finding. CSF is largely separated from the blood by the blood-brain barrier, and the presence of DMT in CSF is consistent with (though not proof of) central nervous system synthesis rather than simply dietary or metabolic origin from peripheral tissues.
The INMT enzyme finding adds to the picture. INMT is present in brain tissue, lung tissue, and other organs. It catalyzes the methylation of tryptamine to DMT (and of other tryptamines in the family). Its presence in the brain means the biochemical machinery for DMT synthesis is available in the central nervous system.
The Evidence, Tiered
| Claim | Evidence | Tier |
|---|---|---|
| DMT is present in the human body | Detected in blood, urine, CSF in multiple studies | Tier 1 — confirmed |
| DMT is synthesized in the human brain | INMT enzyme present in brain tissue; CSF detection consistent with CNS synthesis | Tier 2 — strongly suggested; not directly confirmed |
| Pineal gland is primary synthesis site | INMT expression in pineal tissue; proposed by Strassman; some rodent evidence | Tier 2 — plausible; not confirmed in humans |
| Endogenous DMT contributes to dreams | Speculative; no direct evidence; timing doesn't match REM DMT release hypothesis | Tier 3 — coherent but unconfirmed |
| DMT is released in near-death states | Speculative; some rodent data showing elevated DMT at cardiac arrest (Borjigin et al.) | Tier 2-3 — suggestive in animal models; not confirmed in humans |
| Endogenous DMT mediates mystical/psychedelic-like states | No direct evidence in humans; theoretical framework only | Tier 3 — hypothesis only |
The Strassman Hypothesis
Rick Strassman, whose DMT research at the University of New Mexico in the early 1990s was the first approved human DMT study in decades, developed a hypothesis in his book DMT: The Spirit Molecule that the pineal gland synthesizes and releases DMT during specific physiological states — particularly at birth, death, and during deep meditation or near-death experiences.
This hypothesis generated enormous interest. It also requires careful tiering:
The pineal gland contains INMT enzyme activity (in animals, more clearly than in humans). It synthesizes melatonin and serotonin. It is accessible enough from the bloodstream to release compounds into the brain if it synthesizes them. It has a long history of mystical and spiritual significance — Descartes called it the seat of the soul.
What has not been demonstrated: that the human pineal gland synthesizes DMT in amounts sufficient to produce psychedelic-like effects, or that it specifically releases DMT during the proposed states. The hypothesis remains exactly that — a hypothesis with some supporting evidence but not confirmation.
The question of whether the pineal gland releases DMT during near-death states is separate from the question of whether DMT is endogenous in the brain. The first is speculative. The second is confirmed. Conflating them — which popular accounts frequently do — misrepresents what the science actually shows.
The University of Michigan Rodent Study
A significant 2019 paper by Borjigin and colleagues at the University of Michigan reported detecting elevated DMT in rat brains during cardiac arrest — levels approaching psychoactive ranges. This was the first direct evidence consistent with (not proof of) DMT playing a role in near-death experiences.
Limitations: this was conducted in rats, not humans. The elevation was detected using a specific method and in a specific brain region. The finding needs replication. Extrapolating from rodent cardiac DMT levels to human NDE phenomenology involves significant inferential distance.
But the finding is Tier 2: it is real data consistent with the Strassman hypothesis, produced by mainstream researchers, published in a peer-reviewed journal. It moves the hypothesis from purely speculative to empirically engaged.
What It Would Mean If It's True
If DMT is synthesized and released in the human brain in psychoactive amounts during specific states, the implications would be significant:
The apparent strangeness of spontaneous mystical experiences, near-death visions, and out-of-body experiences would have a pharmacological explanation. These experiences wouldn't require supernatural mechanisms — the brain itself contains the mechanism for producing them.
This would also mean that the boundary between ordinary consciousness and the profound alterations produced by external DMT administration is not as sharp as assumed. The brain has the hardware for DMT-level experiences built in; external DMT is accessing the same system through a pharmacological shortcut.
The Technospermia Lens
Technospermia: The Receiver Built Into the Hardware
If DMT is endogenously produced in the human brain, the Technospermia argument gains its most direct biological evidence: not only were DMT-containing plants seeded into the biosphere, but the receiver — the endogenous system that produces and responds to DMT — was built into the biological hardware. You cannot seed a radio signal without building a radio. The endogenous DMT system would be the receiver that makes the seeded plant compounds meaningful rather than merely psychoactive.
The Technospermia theory argues that psychoactive plants and fungi were deliberately seeded. The endogenous DMT evidence adds a compelling layer: the human brain appears to produce DMT itself. If so, the relationship between the seeded plants and the human receptor system is not accidental chemical correspondence but a designed interface — plant compounds and endogenous brain chemistry using the same molecular key.
Tier 3 for the designed-interface interpretation. Tier 1 for the DMT detection itself. Tier 2 for the CNS synthesis and near-death release hypotheses.
Continue reading: DMT in the Brain — Deep Dive · DMT — The Complete Guide
Share this transmission